Basics & Tracers - Glow & Go Juice
- Principle: Gamma camera detects $\gamma$-rays from tracers in thyroid, assessing function & morphology.
- Key Radiotracers:
| Tracer | $T_{1/2}$ | Energy ($\gamma$) | Dose (Adult) | Mechanism | Notes |
|---|---|---|---|---|---|
| $^{99m}$TcO$_4^-$ | 6h | 140 keV $\gamma$ | 2-10 mCi | Trapped only | Most common; low radiation |
| $^{123}$I | 13.2h | 159 keV $\gamma$ | 100-400 µCi | Trapped & Organified | Ideal physiology; good for ectopic tissue |
| $^{131}$I | 8d | 364 keV $\gamma$ | 5-10 µCi (scan) | Trapped & Organified | Therapy ($\beta^-$); high radiation (scan) |
⭐ $^{99m}$Tc pertechnetate is trapped by thyroid follicular cells via the NIS symporter but is not organified, unlike iodine isotopes.
Why & Why Not - Scan Signals
- Indications (Why - Interpreting Signals):
- Thyrotoxicosis: Differentiate Graves'' disease (diffuse ↑ uptake) vs. Thyroiditis (↓ uptake).
- Thyroid Nodules: Evaluate function (hot, warm, cold). Cold nodules warrant further investigation (e.g., FNAC).
- Ectopic Thyroid Tissue: Detect uptake in aberrant locations (e.g., lingual, substernal).
- Congenital Hypothyroidism: Assess for agenesis (no uptake) or dyshormonogenesis.
- Post-Thyroidectomy: $I-131$ scan for remnant tissue or metastases (uptake indicates presence).
- Contraindications/Limitations (Why Not - Affecting Signals or Safety):
- Pregnancy (especially $I-131$; $Tc-99m$ pertechnetate is relatively contraindicated).
- Breastfeeding (requires temporary cessation; duration depends on radiopharmaceutical).
- Recent Iodine Exposure: Contrast media, amiodarone → ↓ tracer uptake.
- Thyroid Hormone Therapy: Suppresses TSH → ↓ tracer uptake.
⭐ Thyroid scintigraphy is crucial for differentiating causes of thyrotoxicosis, especially distinguishing Graves'' disease (high uptake) from thyroiditis (low uptake).
How-To & Normal View - Picture Perfect Thyroid
- Procedure:
- Administer radiotracer (e.g., $^{\text{99m}}$Tc-pertechnetate, $^{\text{123}}$I, $^{\text{131}}$I).
- Uptake time: 20 min for $^{\text{99m}}$Tc; 4-6h & 24h for $^{\text{123}}$I.
- Imaging: Gamma camera, anterior view; patient supine, neck extended.
- Normal Findings:
- Butterfly-shaped gland; two lobes, connecting isthmus.
- Homogeneous, symmetric tracer distribution.
- Normal uptake: $^{\text{123}}$I: 10-30% (24h); $^{\text{99m}}$Tc: 0.5-4% (20 min).
- 📌 "Perfectly Pictured Thyroid": Uniform, symmetric.
⭐ A normal thyroid scan shows homogeneous, symmetric tracer uptake in both lobes, with the isthmus often visible.
Hot, Cold & Sick - Nodule Nuisance News
Interpreting thyroid scintigraphy focuses on nodule activity and diffuse changes.
-
Nodule Types & Significance:
Feature Hot Nodule Cold Nodule Tracer Uptake ↑ (Hyperfunctioning) ↓ (Hypofunctioning) Malignancy Risk Low (<1%) Higher (15-20%) TSH Often ↓ Normal / ↑ Common Cause Toxic Adenoma, MNG Cyst, Colloid, Cancer Next Step Treat if toxic US + FNA 📌 Mnemonic: Cold is Cancer Concern.
-
Diffuse Patterns:
- Graves': Diffusely ↑ uptake.
- Thyroiditis (Subacute): Initially ↓ uptake (thyrotoxic phase), then ↑ (recovery).
- Hashimoto's: Patchy, heterogeneous uptake. May show cold areas.
⭐ Most thyroid cancers appear as 'cold' nodules on scintigraphy because malignant cells are typically less efficient at trapping or organifying iodine/technetium.
High‑Yield Points - ⚡ Biggest Takeaways
- 99mTc-pertechnetate (trapping) is common; 123I (trapping & organification) for cancer, dyshormonogenesis.
- Hot nodules are rarely malignant (<1%); cold nodules have higher malignancy risk (15-20%).
- Graves' disease shows diffusely increased, homogenous uptake in the entire thyroid gland.
- Toxic Multinodular Goiter (TMNG): multiple, discrete hot nodules with suppressed normal tissue.
- Subacute thyroiditis (de Quervain's) typically shows markedly decreased or absent tracer uptake.
- Discordant nodules (99mTc hot, 123I cold) suggest impaired organification, increasing malignancy concern.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app